Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 1

Grady Wulff
February 23, 2023

View both parts of the latest episode of our Meet the Analyst series where our Market Analyst, Grady Wulff, sits down with Dr. Tara Speranza, Healthcare & Biotech Analyst at Bell Potter, to discuss her outlook on the stocks she covers, Orthocell (ASX:OCC), Microba Life Sciences (ASX:MAP), and Monash IVF Group (ASX:MVF).

Take a look at Dr. Tara’s journey, her approach to analysing a company, and the first stock to be discussed, Orthocell (ASX:OCC).

In this video, Dr. Tara discusses:
– (0:59) Becoming a Bell Potter Analyst
– (2:56) Approaches to analysing a company
– (7:18) Orthocell’s global 25-year exclusive agreement
– (7:53) Orthocell’s TGA approval for its Remplir device
– (8:44) Orthocell’s speculative buy rating

Note: This interview was filmed on 7 February 2023.

 

View Part 2 here.

APN AREIT Fund

Bell Direct
January 24, 2019

Investing in Commercial Property

Julia Lee
January 24, 2019

Market Update

Julia Lee
January 17, 2019

2018 Yearly Wrap

Julia Lee
December 27, 2018

Market Update

Julia Lee
December 21, 2018

Market Update

Julia Lee
December 18, 2018

Market Update

Julia Lee
December 13, 2018

Market Update

Julia Lee
December 5, 2018

Market Update

Julia Lee
December 3, 2018

Market Update

Julia Lee
November 30, 2018

Market Update 28 Nov

Julia Lee
November 29, 2018

November Market Overview

Julia Lee
November 29, 2018